T21	Exp 108 129	The adoptive transfer
T22	Exp 238 252	the regression
T23	Exp 256 297	the poorly immunogenic murine melanoma D5
T24	Exp 351 355	when
T25	Exp 430 434	that
T26	Exp 299 311	The efficacy
T27	Exp 315 337	the activated LN cells
T28	Exp 356 377	the sensitizing tumor
T29	Exp 787 807	the protein tyrosine
T30	Exp 850 870	the NF-kappaB family
T31	Exp 915 925	The levels
T32	Exp 1370 1374	they
T33	Exp 1347 1351	that
T34	Exp 1239 1249	the levels
T35	Exp 1418 1440	the cytoplasmic levels
T36	Exp 1670 1695	the nuclear translocation
T37	Exp 1734 1738	that
T38	Exp 1739 1751	the recovery
T39	Exp 1802 1833	the T cell receptor/CD3 complex
T40	Exp 1886 1901	the acquisition
T41	Exp 1710 1724	These findings
R6	Coref Anaphora:T25 Antecedent:T42
R7	Coref Anaphora:T33 Antecedent:T43
R8	Coref Anaphora:T32 Antecedent:T44
T1	Protein 208 221	interleukin 2
T2	Protein 223 227	IL-2
T3	Protein 444 492	granulocyte/macrophage-colony-stimulating factor
T4	Protein 518 522	IL-2
T5	Protein 816 822	p56lck
T6	Protein 827 833	p59fyn
T7	Protein 929 935	p56lck
T8	Protein 940 946	p59fyn
T9	Protein 1131 1135	IL-2
T10	Protein 1158 1164	p56lck
T11	Protein 1169 1175	p59fyn
T12	Protein 1253 1259	p56lck
T13	Protein 1261 1267	p59fyn
T14	Protein 1444 1449	c-Rel
T15	Protein 1454 1459	Rel A
T42	Exp 424 428	D5G6
T43	Exp 1344 1346	LN
T44	Exp 1313 1330	activated T cells
